Additionally, anti-tumoral activity of 4-1BB signaling was shown to be correlated with enhanced survival in a study done by Ju et al. where 4-1BB-intact mice demonstrated longer survival compared to 4-1BB-deficient mice in a melanoma model (60). This evidence concerns the gene TNFRSF9 and melanoma.